NANOVIRICIDES, INC. Business Finance Contracts & Agreements
61 Contracts & Agreements
- Credit Agreements (1 contract)
- Exchange Agreements (3)
- Investment Agreements (1)
- Note Agreements (2)
- Purchase Agreements (7)
- Registration Rights Agreements (1)
- Stock Agreements (18)
- Subscription Agreements (7)
- Underwriting Agreements (3)
- Waiver Agreements (6)
- Warrant Agreements (12)
- Line of Credit Agreement between the Company and Dr. Anil R. Diwan, dated November 13, 2023 (Filed With SEC on February 16, 2024)
- Convertible Promissory Note between the Registrant and TheraCour, effective July 19, 2023 (Filed With SEC on September 1, 2023)
- Deferred Expense Exchange Agreement between the Registrant and TheraCour effective July 19, 2023 (Filed With SEC on September 1, 2023)
- Underwriting Agreement with Kingswood Capital Markets, a Division of Benchmark Investments, Inc. dated July 8, 2020 (Filed With SEC on July 13, 2020)
- Placement Agent Agreement, dated May 21, 2020 by and between among NanoViricides, Inc. Maxim Group LLC and Kingswood Capital Markets, a division of Benchmark Investments, Inc (Filed With SEC on May 22, 2020)
- Form of Securities Purchase Agreement dated May 21, 2020 by and between NanoViricides, Inc. and certain purchasers (Filed With SEC on May 22, 2020)
- Form of Common Stock Purchase Agreement (Filed With SEC on January 28, 2020)
- Form of Exchange Agreement (Filed With SEC on January 28, 2020)
- Underwriting with Aegis Capital Corp. dated January 21, 2020 (Filed With SEC on January 27, 2020)
- Form of Series A Conversion Waiver (Filed With SEC on January 8, 2020)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on January 8, 2020)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on January 8, 2020)
- Form of Series A Conversion Waiver (Filed With SEC on January 7, 2020)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on January 7, 2020)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on January 7, 2020)
- Form of Series A Conversion Waiver (Filed With SEC on December 23, 2019)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on December 23, 2019)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on December 23, 2019)
- Deferred Expense Exchange Agreement (Filed With SEC on December 19, 2019)
- Open End Mortgage Note (Filed With SEC on December 19, 2019)
- Form of Series A Conversion Waiver (Filed With SEC on December 17, 2019)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on December 17, 2019)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on December 17, 2019)
- Form of Series A Conversion Waiver (Filed With SEC on November 29, 2019)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on November 29, 2019)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on November 29, 2019)
- Form of Series A Conversion Waiver (Filed With SEC on September 27, 2019)
- Form of Representatives Warrant (Filed With SEC on September 27, 2019)
- Form of Common Stock Purchase Warrant (Filed With SEC on September 27, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on September 27, 2019)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on September 27, 2019)
- Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock (Filed With SEC on September 27, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 27, 2019)
- Form of Common Stock Purchase Warrant (Filed With SEC on March 1, 2019)
- Form of Securities Purchase Agreement dated February 27, 2019 by and between NanoViricides, Inc. and certain purchasers (Filed With SEC on March 1, 2019)
- Form of Warrant (Filed With SEC on May 4, 2018)
- AGREEMENT OF PURCHASE AND SALE (Filed With SEC on January 7, 2015)
- COMMON STOCK PURCHASE WARRANT (Filed With SEC on January 24, 2014)
- COMMON STOCK PURCHASE WARRANT __________ (Filed With SEC on September 13, 2013)
- CERTIFICATE OF DESIGNATION, RIGHTS ANDPREFERENCES OF SERIES C CONVERTIBLE PREFERRED STOCK OF NANOVIRICIDES, INC. (Continued) (Filed With SEC on July 2, 2012)
